Neostigmine Methylsulfate Injection
Product Images NDC 70700-172

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 70700-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neostigmine-spl-carton-1-10 (Neostigmine Spl Carton 1 10)

This text appears to be a label for a medication called Neostigmine Methylsulfate Injection, USP. It contains 1 mg/mL and is for intravenous use only, with instructions to consult the package insert for directions for use. The label also includes information about the product's ingredients and storage instructions. The medication is manufactured for Xiromed, LLC and was produced in India.*

FDA Label Image

Neostigmine-spl-carton-10-10 (Neostigmine Spl Carton 10 10)

FDA Label Image

Neostigmine-spl-carton-5-1 (Neostigmine Spl Carton 5 1)

This is a description of a medication called Neostigmine Methylsulfate injection, USP, which comes in a 16 mL or 10 mL multiple dose vial. Each milliliter contains Neostigmine Methylsulfate, phenol, sodium acetate trihydrate, and water for injection. The medication is for intravenous use, and it is recommended to store it in the carton until time of use and protect it from light. The manufacturer is Xiramed, LLC, located in Florham Park, N 07932, and the product is made in India. Directions for use can be found in the package insert.*

FDA Label Image

Neostigmine-spl-carton-5-10 (Neostigmine Spl Carton 5 10)

Neostigmine Methylsulfate Injection, USP is a prescription drug for intravenous use. It comes in 10% 10mL multiple dose vials, each containing neostigmine methylsulfate 0.5mg, phenol 45mg, sodium acetate trihydrate 0.2mg, and water for injection. The pH level is adjusted with sodium hydroxide/acetic acid as necessary. It should be protected from light and stored in a carton at controlled room temperature. Manufactured for Xiromed LLC and distributed under NDC 70700-171-23. Directions are available in the package insert.*

FDA Label Image

Neostigmine-spl-structure (Neostigmine Spl Structure)

FDA Label Image

Neostigmine-spl-vial-10 (Neostigmine Spl Vial 10)

FDA Label Image

Neostigmine-spl-vial-5 (Neostigmine Spl Vial 5)

Neostigmine Methylsulfate Injection is a prescription medication used for intravenous use. It comes in a 10 mL multiple dose vial with each mL containing Neostigmine Methylsulfate 0.5 mg, Phenol 45 mg, Sodlum Acetate Trihydrate 02 mg, and Water for Injection. The pH of the water is adjusted using Sodium Hydroxide / Acetic Acid. The injection should be protected from light and stored in a box until used between 20°C to 25°C. The medication is manufactured for Xiromed, LLC of Flerham Park, US. The drug is a product of India and has a lot number and expiration code on the vial.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.